Effects of human soluble BAFF synthesized in Escherichia coli on CD4 + and CD8+ T lymphocytes as well as NK cells in mice

XiaoXiao Shan,Long Chen,Meng Cao,Ling Xu,Shuangquan Zhang

DOI: https://doi.org/10.33549/physiolres.930816

2006-01-01

Physiological Research

Abstract:B cell-activating factor belonging to the TNF family ( BAFF, also called BLyS, TALL-1, zTNF-4, or THANK) is an important survival factor for B lymphocytes. In this study, we injected mouse abdominal cavity with human soluble BAFF (hsBAFF, 0.01, 0.1, 0.5, 2 mg/kg body mass) synthesized in Escherichia coli. On the 8th day after injection, we investigated the effects of hsBAFF on immune functional activities of splenic B lymphocytes, CD4(+) and CD8(+) T lymphocytes and natural killer (NK) cells in mice. The results showed that B lymphocyte proliferation significantly increased in hsBAFF-treated groups with dosages of 0.1 mg/ kg (p < 0.05), 0.5 and 2 mg/ kg (p < 0.01). We observed a dose-dependent increase of CD4(+) T lymphocyte percentage and significantly higher values in 0.5 and 2 mg/kg hsBAFF-treated groups (p < 0.05 and p < 0.001, respectively) compared to control group, but CD8(+) T lymphocyte percentage remained unchanged. The ratio of CD4(+) to CD8(+) T lymphocytes rose with increasing hsBAFF dosage (p < 0.05 for 2 mg/ kg hsBAFF vs. control). Significantly stronger NK cell activities were found in 0.5 and 2 mg/ kg hsBAFF-treated groups (p < 0.05). The main finding of this study is that the hsBAFF can enhance immune responses in the body by increasing B lymphocyte and CD4(+) T lymphocyte function as well as elevating NK cell activity.